ATEX.NASDAQAnterix INC

Form 4: Anterix CFO Timothy Gray Awarded Stock Options

Sentiment:

SEC Form 4 Filing


Anterix's Chief Financial Officer, Timothy Gray, was granted 40,664 stock options on January 16, 2025, which vest over three years.

Summary

  • Timothy Gray, the Chief Financial Officer of Anterix Inc., was granted 40,664 stock options on January 16, 2025.
  • The options have an exercise price of $27.83 per share.
  • The options vest in three equal annual installments, starting on January 16, 2025, contingent on Mr. Gray's continued employment with Anterix.
  • The options expire on January 16, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management and shareholder interests. There are no negative implications.

Positives

  • The granting of stock options to the CFO aligns his interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment from the CFO.

Future Outlook

The stock options will vest over the next three years, subject to the CFO's continued employment.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

  • Stock option grants are a standard practice for executive compensation across various industries, including technology and telecommunications, where Anterix operates.
  • The vesting schedule of three years is also typical, encouraging long-term commitment from executives.
  • Companies like Verizon, AT&T, and T-Mobile also use stock options as part of their executive compensation packages.

Stakeholder Impact

  • Shareholders may view this positively as it aligns the CFO's interests with the company's long-term performance.
  • Employees may see this as a sign of stability and commitment from the leadership team.

Key Dates

DateDescription
01/16/2025Date of the stock option grant and the start of the vesting period.
01/21/2025Date the form was signed by the Attorney-in-Fact.
01/16/2035Expiration date of the stock options.

Keywords

stock options, executive compensation, insider trading, CFO, Anterix, ATEX

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.